You have clicked a link to access information on a new website, so you will be leaving Because this new site is independent, Diamond Hill Capital Management, Inc. neither manages nor assumes responsibility for its content. Are you ready to move forward?

Is Pharma Reentering a Golden Age of Innovation?

Innovation and productivity in the pharmaceutical industry has been in steady decline for decades. However, we believe the industry is poised for a comeback.

The views expressed are those of Diamond Hill as of September 2020 and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of results, or investment advice.

As of July 31, 2020, Diamond Hill owned equity shares of Gilead Sciences, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Alphabet, Inc. (Classes A&C), Novartis AG, Astellas Pharma, Inc. and Roche Holdings AG.

back to top